Home Tags SBT6050

Tag: SBT6050

How the Next Generation Antibody Drug Conjugates Expands Beyond Cytotoxic Payloads...

Antibody-drug Conjugates or ADCs combine the selectivity of antibodies with the efficacy of small molecule drugs, allowing for more precise, targeted, therapeutic applications.Combining the...

Silverback Raises U.S. $78.5 Million to Advance SBT6050 into the Clinic...

Seattle-based Silverback Therapeutics™, a biopharmaceutical company pioneering a new class of immune-modulating ImmunoTAC™ drug conjugates targeting previously inaccessible disease pathways, confirmed that it has...